Skip to content
Screener

Maze Therapeutics MAZE Current Debt

Current Debt at other companies

GPA
General Purpose Acquisition Corp.GPAC
$103.85K-98.4%
Dycom Industries logo
Dycom IndustriesDY
$6M-60.0%
Dollar General logo
Dollar GeneralDG
$13.3M-32.1%
Target logo
TargetTGT
$1.13B-0.5%
HEICO logo
HEICOHEI
$3.4M-10.2%
Barnes Group logo
Barnes GroupB
$506K+1,645%

Other financials

Income statement

See full
Revenue$20.0M—
Operating income-$48.0M-31.7%
Net income-$44.7M-32.8%
EPS (diluted)-$0.76+1.3%

Balance sheet

See full
Cash & equivalents$202.6M-23.4%
Total debt$60.4M+142%
Total equity$453.1M+72.8%
Total assets$531.6M+75.2%

Cash flow

See full
Operating cash flow-$15.1M+49.9%
CapEx$107.0K-72.8%
Free cash flow-$15.2M+50.2%

Valuation

See full
Market cap$1.51B+156%
Enterprise value$1.37B+290%

Returns & leverage

See full
Return on equity-37.3%—
Debt / equity0.1×0.0×
Current ratio18.3×+4.7×

Where this comes from

Reported directly by Maze Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 4:48 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344903

FAQ

What is Maze Therapeutics's current debt?
Maze Therapeutics (MAZE) reported current debt of $0 in Q2 2026.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Ask your AI about Maze Therapeutics's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude